Open Orphan plc changes its name to hVIVO plc, learn more here.

Presentation

Pre-existing NP specific T-cell response correlates with reduction of symptoms in a human influenza challenge model

hVIVO's presentation during the Options X conference in 2019 about pre-existing NP specific T-cell response correlates with reduction of symptoms in a human influenza challenge model.


Download the document

chevron-down